ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).

ClinicalTrials.gov ID: NCT00332241

Public ClinicalTrials.gov record NCT00332241. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Double-Blind, Randomized, Placebo-Controlled, Flexible-Dosed, Parallel-Group Study of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Study identification

NCT ID
NCT00332241
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
98 participants

Conditions and interventions

Interventions

  • Aripiprazole Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2006
Primary completion
Mar 31, 2008
Completion
Mar 31, 2008
Last update posted
May 12, 2026

2006 – 2008

United States locations

U.S. sites
9
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
Marsella, Gregory Boca Raton Florida 33432
Child Neurology Associates, Pc Atlanta Georgia 30342
University Of Louisville Louisville Kentucky 40202
Neurobehavioral Medicine Group Bloomfield Hills Michigan 48302
Center For Psychiatry And Behavioral Medicine Las Vegas Nevada 89128
Suny - Stony Brook School Of Medicine Stony Brook New York 11794
Univ Of Nc Chapel Hill North Carolina 27599
Ut Medical Group Memphis Tennessee 38105
Red Oak Psychiatry Associates, Pa Houston Texas 77090

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00332241, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 12, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00332241 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →